197 ECM REMODELLING AFFECTS SOX9-GSK3beta DEPENDENT CONTROL OF beta-CATENIN IN CHONDROCYTES  by Borzì, R. et al.
S94 Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256
Methods: We collected six age - and sex-matched probes of human
cartilage before undergoing total knee joint replacement under from OA
patients. Cells from macroscopic “normal” and arthritic areas were har-
vested from each knee. Tissue specimens were extracted under sterile
conditions and one part immediately snap frozen in liquid nitrogen for
methylation array (Human CpG Island Microarray Kit, Agilent Inc., Cali-
fornia, USA). The other part was cultured. After digestion, the cells were
treated with 10 uM of demethylation agent, 5-AZA-deoxy-cytidine, over
a period of six days. DNA was isolated using Qiagen QIAamp DNA Micro
Kit (QIAGEN Inc., California, USA) according to manufacturer’s protocol.
After harvesting the cells, RNA was extracted using the Trizol method and
cDNA was transcribed. Gene expression was performed with the Taqman®
Realtime PCR Assay using standardized primers.
Results: After analyzing microarray data 1246 genes, where of 936 have
been identiﬁed, showed statistical differences between arthritic and non-
arthritic areas. According to the p-value (p<0,5) and geometric value
(arthritic/non arthritic) we picked out the following candidate genes; GLA,
ADORA3, LAMA4, ORMDL2, PRMT5, WDR46. After treatment with 5-Aza-
deoxy-cytidine we observed a signiﬁcant increase of the candidate genes
expression in human arthritic cartilage cell cultures compared to the
untreated macroscopically intact controls.
Conclusions: The considerable increase of the investigated gene’s ex-
pression in cell culture that correlated with the data gained from the
methylation speciﬁc array lead us to the thought, that methylation may
play an important role in the pathogenesis of OA. Further research in
the ﬁeld of microarray technique, including protein data, may lead us to
therapeutic aspects of OA in the future.
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Purpose: Our recent ﬁndings indicate that MMP-13 or IKKalpha KD im-
paired ECM remodeling resulted in pronounced alterations in the pattern
of Sox9 nuclear localization along with changes in beta-catenin levels and
activation status and disruption of chondrocyte differentiation. To mecha-
nistically investigate crosstalk between ECM remodeling and beta-catenin,
we evaluated the expression of GSK3beta (a key component of the beta-
catenin degradation complex) in MMP-13 and IKKalpha KD micromasses
and in cartilage samples with different degrees of ECM remodeling and the
effects of inhibiting GSK3beta activity on chondrocyte differentiation.
Methods: The subcellular distribution and co-localization of Sox9 and
GSK3beta were investigated in 1 week micromasses by confocal microscopy
on sections passing through nuclei. In addition, GSK3beta expression was
assessed in immunoblots of 1 week micromass lysates, upon normal-
ization against GAPDH and its Sox9 interaction was also investigated in
co-immunprecipitation experiments in conjunction with western blotting.
Full thickness slices of cartilage from either normal/early OA or late OA car-
tilage samples were also analyzed for GSK3beta expression in conjunction
with ECM status by Safranin-O staining. The phenotypic effects of inhibit-
ing GSK3beta were assessed by comparisons of control and 5mM LiCl -
treated high density monolayer cultures (in 5-replicates) and micromasses
maturing over a 1-3 week time course.
Results: GSK3beta staining was predominantly nuclear in control, MMP-
13 KD and IKKalpha KD micromass samples. However, unlike the GL2
controls, nuclear Sox9 co-localized with GSK3beta in MMP-13 KD and
IKKalpha KD chondrocytes. Surprisingly, western blotting revealed higher
levels of GSK3beta expression in IKKalpha KD micromasses, part of which
immunoprecipitations showed to be in complexes with Sox9. Noteworthy,
in cartilage tissue with strong safranin-O staining, GSK3beta expression
was also markedly higher in middle zone chondrocytes. Chondrocytes
cultured in the presence of 5 mM LiCl deposited a higher amounts of
calcium as judged by spectrophotometric analysis of alizarin red staining.
Higher levels of MMP-13 activity (as indicated by stronger expression of its
processed, active form in western blots) were also observed in maturing
micromasses with impaired GSK3beta activity. The greater extent of ECM
remodeling in LiCl treated micromasses was in keeping with their reduced
size and accelerated terminal differentiation.
Conclusions: We ﬁnd that the impaired ECM remodeling in MMP-13 or
IKKalpha KD in micromasses is associated with reduced levels of active
beta-catenin and the presence of enhanced levels of nuclear Sox9 in com-
plexes with GSK3beta. Moreover, middle zone cartilage with more intact
ECM also presents a greater degree of nuclear Sox9 in association with
higher levels of GSK3beta. Taken together these data suggest that prior to
their undergoing ECM remodeling and subsequent terminal differentiation
chondrocytes have a signiﬁcant amount of their GSK3beta in nuclear
complexes with Sox9, which could contribute to enhanced beta-catenin
degradation as also recently reported in other cellular models. Sox9 de-
pendent nuclear localization of the beta-catenin degradation complex may
be an important component of the molecular constraints that maintain
articular chondrocytes in their proper arrested state in healthy cartilage.
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Purpose: To investigate the mechanism of the inhibitory action of high
molecular weight hyaluronic acid (HA) on production of matrix metal-
lopoteinases (MMPs) induced by IL-6 in human articular chondrocytes.
Methods: Human articular chondrocytes were stimulated by IL-6 and
soluble IL-6 receptor (sIL-6R) with or without HA for 24 h and the pro-
duction of MMP-1, MMP-3 and MMP-13 was measured. Phosphorylation of
extracellular signal-regulated kinase (ERK), signal transducer and activator
of transcription (STAT) and mitogen-activated protein kinase kinase (MEK)
in IL-6+sIL-6R-treated chondrocytes was detected by Western blotting.
Expression levels of mitogen-activated protein kinase phosphatase (MKP-1)
in HA-treated chondrocytes were assessed by real-time PCR and Western
blotting.
Results: IL-6 alone did not induce MMP-1, MMP-3 and MMP-13 production
in human articular chondrocytes. However, in combination with sIL-6R,
IL-6 increased MMP production in a concentration-dependent manner.
Anti-IL-6R antibody suppressed MMP production induced by IL-6+sIL-6R.
We examined the effects of parthenolide (PAR, a STAT inhibitor) and
PD98059 (PD, a MEK-ERK inhibitor) on the production of MMP-1, MMP-3
and MMP-13 induced by IL-6+sIL-6R. After pre-incubation with PAR or PD,
chondrocytes were stimulated with IL-6+sIL-6R for 24 h and then MMP-1,
MMP-3 and MMP-13 concentrations were measured. IL-6+sIL-6R signiﬁ-
cantly induced MMP-1, MMP-3 and MMP-13 productions and suppression
of the MEK-ERK signal pathway by PD resulted in a marked decrease of
IL-6+sIL-6R-induced MMP-1, MMP-3 and MMP-13 production. In contrast,
PAR only slightly decreased the production of MMPs from chondrocytes.
Previously we found that HA inhibited IL-6-induced MMP production in
chondrocytes. We examined if anti-CD44 antibody or anti-ICAM1 anti-
body reversed HA-induced suppression of MMP production by IL-6+sIL-6R.
IL-6+sIL-6R showed remarked increase of MMP production and HA sig-
niﬁcantly suppressed IL-6+sIL-6R-induced MMP production. The inhibitory
effect of HA on IL-6+sIL-6R-induced MMP production was decreased by
anti-CD44 antibody, but not anti-ICAM-1 antibody. To further analyze the
inhibitory action of HA on MAPK signal pathways, we tested whether
HA blocked the phosphorylation of MEK and ERK. IL-6+sIL-6R promoted
the phosphorylation of both MEK and ERK. However, HA treatment re-
duced the phosphorylation of ERK, but not MEK. Then we examined if
HA could induce MKP-1, a negative regulator of ERK1/2. HA treatment
induced the expression of MKP-1 mRNA in untreated chondrocytes. We
also conﬁrmed by Western blotting that MKP-1 protein was induced by HA
in IL-6+sIL-6R-treated or untreated chondrocytes.
To determine the involvement of MKP-1 in HA-induced suppression of
MMP production, we tested whether MKP-1 inhibitor blocked the effect of
HA. MKP-1 inhibitor clearly reversed the suppressive effect of HA on MMP
production, to the level of the negative control.
Conclusions: Our study clearly demonstrated that HA suppressed IL-6-
induced MMP production by chondrocytes via MKP-1 induction through
CD44 signaling.
